For the quarter ending 2025-12-31.
| Income Statement | 2025-12-31 | 2025-09-30 | ||
|---|---|---|---|---|
| Revenue | 0 | 4,250 | ||
| General and administrative expenses | 52,949 | 41,154.5 | ||
| Loss from operation | -52,949 | -36,904.5 | ||
| Loss before provision for income taxes | -52,949 | -36,904.5 | ||
| Interest income | 1 | 0.5 | ||
| Total other income | 1 | 0.5 | ||
| Loss before income taxes | -52,948 | -36,904 | ||
| Provision for income taxes | - | 512.5 | ||
| Net loss | -52,948 | -37,416.5 | ||
| Basic loss per common share | -0.01 | -0.003 | ||
| Basic weighted average number of common shares used in per share | 25,441,042 | 6,360,260.5 | ||
| Diluted loss per common share | -0.01 | -0.003 | ||
| Diluted weighted average number of common shares used in per share | 25,441,042 | 6,360,260.5 | ||
Bodhi Tree Biotechnology Inc (BDTB)
Bodhi Tree Biotechnology Inc (BDTB)